Previous 10 | Next 10 |
Stealth BioTherapeutics Corp (MITO) Q2 2021 Earnings Conference Call August 05, 2021, 08:30 ET Company Participants Henry Hess - Chief Legal Counsel Irene McCarthy - President, CEO, Secretary & Director James Carr - Chief Clinical Development Officer Brian Blakey - Chief Business Officer ...
The following slide deck was published by Stealth BioTherapeutics Corp in conjunction with their 2021 Q2 earnings call. For further details see: Stealth BioTherapeutics Corp 2021 Q2 - Results - Earnings Call Presentation
Stealth BioTherapeutics (NASDAQ:MITO): Q2 GAAP EPS of -$0.03 misses by $0.01. Cash and cash equivalents of $30.76M Shares +1.45% PM. Press Release For further details see: Stealth BioTherapeutics EPS misses by $0.01
Stealth BioTherapeutics Reports Second Quarter 2021 Financial Results And Recent Business Highlights Barth NDA submission expected by month-end Alignment reached with the Division of Rare Disease and Medical Genetics (DRDMG) on design of Phase 3 trial in patients with mitoch...
Stealth BioTherapeutics to Report Second Quarter Financial Results on Thursday, August 5 PR Newswire BOSTON , July 30, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development a...
Stealth BioTherapeutics (MITO) has joined the Rare Disease Company Coalition, an alliance of life science companies committed to discovering, developing, and delivering rare disease treatments.The coalition will engage with policy stakeholders to advocate for impactful drug and healthcar...
Stealth BioTherapeutics Joins the Rare Disease Company Coalition PR Newswire BOSTON , July 7, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of ...
Alterity Therapeutics Limited (ATHE) +57% on a new patent by USPTO.Birks Group (BGI) +49% on re-opening of its retail stores across Canada.Wunong Net Technology Company (WNW) +46%.Spero Therapeutics (SPRO) +23% on $40M equity investment from Pfizer.Bridgeline Digital (BLIN) +21...
3 Penny Stocks to Watch With Big Gains This Week Investing in penny stocks in the past month or so has been filled with a lot of ups and downs. But, as penny stocks investors, this volatility can be a great method to seeing gains (and losses) in your portfolio. In June of 2021, ...
Koss (KOSS) -14%.C3.ai (AI) -11% on FQ4 earnings release.Stealth BioTherapeutics (MITO) -11%.Express (EXPR) -11% on Q1 earnings releaseFireEye (FEYE) -10% after spins out FireEye Products business to Symphony for $1.2B.Bed Bath & Beyond (BBBY) -10%.PetMed Exp...
News, Short Squeeze, Breakout and More Instantly...
Stealth BioTherapeutics Corp. Company Name:
MITO Stock Symbol:
NYSE Market:
Stealth BioTherapeutics Corp. Website:
Stealth BioTherapeutics Corp Announces Completion of Merger PR Newswire BOSTON , Nov. 16, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the ...
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS) PR Newswire SBT-272 Phase 1 safety and tolerability data support further clinical development SBT-272 was neuroprotective...
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders PR Newswire BOSTON , Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused o...